Alexandria Venture Investments, LLC

CIK 1722024 · last filed 2023-10-16

Alexandria Venture Investments, LLC is a corporate insider who has filed 21 SEC Form 4 insider transactions across 18 companies since 2017. The most recent filing, for APLT, was dated Oct 16, 2023. Across all open-market trades the lifetime net is +$31.7M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $82.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$82.83M

Companies

18

Total Filings

21

Lifetime Open-Market Net

$31.73M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Applied Therapeutics, Inc. (APLT) Delisted 10%+ Owner 778,977 $0.10 $80.2K $29.25M 3 2023-10-16
Vigil Neuroscience, Inc. (VIGL) Delisted 10%+ Owner 192,973 $8.05 $1.55M $0 1 2022-01-11
XLO 10%+ Owner 166,423 $8.31 $1.38M $0 1 2021-10-26
Singular Genomics Systems, Inc. (OMIC) Delisted 10%+ Owner 2,645,985 $20.01 $52.95M $0 1 2021-06-01
VOR 10%+ Owner 282,804 $14.36 $4.06M $0 1 2021-02-09
ARS Pharmaceuticals, Inc. (SBTX) Delisted 10%+ Owner 699,412 $5.87 $4.11M $0 1 2020-12-08
Metacrine, Inc. (MTCR) Delisted 10%+ Owner 1,268,795 $0.49 $627.9K $500.0K 1 2020-09-18
KYMR 10%+ Owner 467,932 $86.20 $40.34M $0 1 2020-08-25
RLAY 10%+ Owner 968,365 $14.81 $14.34M $0 1 2020-07-20
RNA 10%+ Owner 502,365 $12.37 $6.21M $0 1 2020-06-16
IMRA 10%+ Owner 293,013 $17.02 $4.99M $0 1 2020-03-16
Korro Bio, Inc. (FREQ) Delisted 10%+ Owner 956,175 $14.98 $14.32M $0 1 2019-10-09
Karuna Therapeutics, Inc. (KRTX) Delisted 10%+ Owner 214,447 $329.83 $70.73M $480.0K 1 2019-07-05
IDYA 10%+ Owner 382,384 $28.98 $11.08M $500.0K 1 2019-05-30
NXTC 10%+ Owner 197,993 $2.08 $410.8K $0 1 2019-05-13
CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted 10%+ Owner 149,637 $33.99 $5.09M $1.00M 1 2018-07-23
EVLO 10%+ Owner 594,443 $0.00 $59 $0 1 2018-05-21
ASNS 10%+ Owner 225,680 $0.08 $17.6K $0 1 2017-11-20

Recent Filings

21 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-10-16 Applied Therapeutics, Inc. (APLT) Delisted Other (J) $0 EDGAR
2022-02-25 Applied Therapeutics, Inc. (APLT) Delisted Other (J) $0 EDGAR
2022-01-11 Vigil Neuroscience, Inc. (VIGL) Delisted Conv (C) +192,973 $0 EDGAR
2021-10-26 XLO Conv (C) +166,423 $0 EDGAR
2021-06-01 Singular Genomics Systems, Inc. (OMIC) Delisted Conv (C) +2,645,985 $0 EDGAR
2021-02-09 VOR Conv (C) +282,804 $0 EDGAR
2020-12-08 ARS Pharmaceuticals, Inc. (SBTX) Delisted Conv (C) +699,412 $0 EDGAR
2020-09-18 Metacrine, Inc. (MTCR) Delisted Mixed +1,307,256 $500.0K EDGAR
2020-08-25 KYMR Conv (C) +467,932 $0 EDGAR
2020-07-20 RLAY Conv (C) +968,365 $0 EDGAR
Showing 110 of 21
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.